CIK 0001870404 · <br>Emerging growth company
CERO THERAPEUTICS HOLDINGS, INC.
Sign in to watch- Tickers
- CERO CEROW
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 871088814
- Phone
- 650-407-2376
- Business address
- 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- CERO THERAPEUTICS HOLDINGS, INC., PHOENIX BIOTECH ACQUISITION CORP.
Securities
- CERO Common stock OTC
- CEROW Common stock OTC
- 4 Other acquisition President acquired 43,300 shares (other)
- 4 Other disposition 10% owner disposed of 5,296,246 shares (other)
- 4 Other acquisition Director acquired 5,828 shares (other)
- 4 Other disposition Director disposed of 5,296,246 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 373,735 shares (other)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
- 25-NSE Other Notification of Removal from Listing
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Shareholder vote results · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 424B3 Offering Prospectus
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Unregistered share sale · Other events
Page 17 of 23 · 445 filings